Share this postSnowball ResearchHeron Therapeutics (HRTX) appoints new CEO with a history of selling companies; brought on board via settlement with activist investors; Kevin Kotler of Broadfin Capital joins the BoardCopy linkFacebookEmailNotesMoreHeron Therapeutics (HRTX) appoints new CEO with a history of selling companies; brought on board via settlement with activist investors; Kevin Kotler of Broadfin Capital joins the BoardApr 26, 2024∙ PaidShare this postSnowball ResearchHeron Therapeutics (HRTX) appoints new CEO with a history of selling companies; brought on board via settlement with activist investors; Kevin Kotler of Broadfin Capital joins the BoardCopy linkFacebookEmailNotesMoreShareHeron Therapeutics (HRTX)807KB ∙ PDF fileDownloadDownload This post is for paid subscribersSubscribeAlready a paid subscriber? Sign inPreviousNext